Trends in Inter Partes Review of Life Sciences Patents

Bloomberg BNA's Patent, Trademark & Copyright Journal published an article written by Monica Grewal, James Hill and Kathryn Zalewski, which provides a statistical analysis of inter partes review proceedings before the Patent Trial and Appeal Board and shows that it is not a ''death squad'' for patents.

First available in September 2012 under the America Invents Act, petitions for inter partes review have become a popular and relatively inexpensive staple in patent litigation. Read the full article

2016-06-07-Trends-in-Inter-Partes-Review-of-Life-Sciences-Patents

Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

Rss Feed
2.22.2025
We need to talk about the F word (‘friction’ in enterprise, that is) 
2.22.2025
The rise of browser-use agents: Why Convergence’s Proxy is beating OpenAI’s Operator 
2.22.2025
Meta launches $50M Meta Horizon Creator Fund 
Build
Document Generator  
Startup Dictionary  
2.20.2025
Corporate Transparency Act: Judge Clears Way for CTA; Reporting Requirements Back in Effect
2.12.2025
Corporate Transparency Act: It’s Still Paused (For Now)
12.27.2024
Corporate Transparency Act: Preliminary Injunctive Relief Reinstated by Fifth Circuit (For Now)